Skip to main content

FDA recall, , Moderate risk

Olympus ShockPulse-SE Lithotripsy System Reusable Probes, Single Use Probes and Generator

The ShockPulse-SE Lithotripsy System can remain in a blinking phase waiting to recognize the transducer due to damage to the plug or receptacle.

What happened

Olympus Corporation of the Americas, based in Center Valley, Pennsylvania, recalled the ShockPulse-SE Lithotripsy System because ongoing investigations identified additional instances of the device Generator remaining in a blinking phase waiting to recognize the transducer. Damage to the transducer plug and/or generator receptacle may cause these issues.

The recall began November 14, 2025, and was added to the FDA's Enforcement Report on February 27, 2026, with distribution nationwide and in Canada, Mexico, Bolivia, Chile, India, China, EU, Singapore, Australia, Korea, and Japan.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

3 products

Match the UDI-DI and model/catalog number listed under your product.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. ShockPulse-SE Lithotripsy System SPL-S ShockPulse-SE Lithotripsy System - Single Use Probes

    UDI-DI
    • 00821925044197
    Model/Catalog number
    • SPL-S
  2. ShockPulse-SE Lithotripsy System - Generator

    UDI-DI
    • 00821925044203
    Model/Catalog number
    • SPL-G
  3. ShockPulse-SE Lithotripsy System SPL-SR ShockPulse-SE Lithotripsy System - Reusable Probes

    UDI-DI
    • 00821925043824
    Model/Catalog number
    • SPL-SR

Recall details

Company began the recall
Sold in

Worldwide distribution - US Nationwide and the countries of Canada, Mexico, Bolivia, Chile, India, China, EU, Singapore, Australia, Korea, and Japan.

Company
Olympus Corporation of the AmericasCenter Valley, Pennsylvania
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98359
Recall numbers
Z-1477-2026 to Z-1479-2026

All recalls from Olympus Corporation of the Americas

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

Summary by Recall Canary, written with AI · summary updated Oct 23, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)